Posted on April 10, 20244/10/24
Understanding ICER’s 2024 Protocol for Assessing Unsupported Price Increases on Prescription Drugs
Posted on March 14, 20243/14/24
Establishing the Pricing and Value Proposition of AI/MedTech Solutions in Healthcare
Posted on February 6, 20242/6/24
Measuring Willingness to Pay: The Next Access Frontier
Posted on June 20, 20236/20/23
Key Considerations When Operationalizing Revenue Management
Posted on June 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on June 12, 20236/12/23
Informing Optimal Pricing Strategies with a Comprehensive Modeling Approach
Posted on May 25, 20235/25/23
The Influx of Generic Launches Leaves Narrow Opportunities for Multiple Sclerosis Access
Posted on May 21, 20235/21/23
Pricing Complexities of a Combination Therapy
Posted on May 17, 20235/17/23